FDA Clears Vivos Therapeutics' Oral Device for Sleep Apnea
Vivos Therapeutics said on Wednesday the US health regulator has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company's shares before the bell.
Stay updated with breaking news from Bnormal Sleep Pattern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivos Therapeutics said on Wednesday the US health regulator has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company's shares before the bell.
The FDA said it is alerting patients of a new safety issue with machines made by the group that are used for the treatment of obstructive sleep apnea.
Restricted sleep of around 6 hours per night may be enough of a reduction to increase the risk for impaired insulin sensitivity in women, particularly if they are postmenopausal, suggests a US trial.
Philips said on Thursday it has reached a settlement to resolve one category of legal claims against it following a major recall of its sleep apnea and respiratory devices.
Sleeping 3 or more hours over or under the average sleep duration of 8 hours increases the risk for type 2 diabetes, regardless of other factors, indicates Dutch study analysis.